Pharmaceutical Business review

Inverness acquires BBI Holdings

The final purchase price consisted of $123.2 million cash and approximately 251,300 shares of Inverness common stock. In addition, existing options to purchase BBI stock have been assumed and have converted into options to purchase approximately 360,000 shares of Inverness common stock.